Bio-View Ltd (BIOV.TA)
ILA 29.4
(0.0%)
ILA 29.4
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 766 Thousand ILS | -33.45% |
| 2022 | 1.15 Million ILS | -60.98% |
| 2021 | 2.95 Million ILS | 145.63% |
| 2020 | 1.2 Million ILS | -64.62% |
| 2019 | 3.39 Million ILS | 292.35% |
| 2018 | -1.76 Million ILS | -24.91% |
| 2017 | -1.41 Million ILS | -129.84% |
| 2016 | 4.73 Million ILS | 23.17% |
| 2015 | 3.84 Million ILS | 53.13% |
| 2014 | 2.51 Million ILS | 329.73% |
| 2013 | -1.09 Million ILS | -163.62% |
| 2012 | 1.71 Million ILS | -56.25% |
| 2011 | 3.92 Million ILS | 2.05% |
| 2010 | 3.84 Million ILS | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 735 Thousand ILS | 0.0% |
| 2024 Q1 | 735 Thousand ILS | 243.7% |
| 2023 Q4 | -511.49 Thousand ILS | -3.65% |
| 2023 FY | 766 Thousand ILS | -33.45% |
| 2023 Q3 | -493.5 Thousand ILS | -187.81% |
| 2023 Q2 | 562 Thousand ILS | 0.0% |
| 2023 Q1 | 562 Thousand ILS | 232.55% |
| 2022 Q2 | -463 Thousand ILS | -192.79% |
| 2022 FY | 1.15 Million ILS | -60.98% |
| 2022 Q4 | -424 Thousand ILS | -127.55% |
| 2022 Q3 | 1.53 Million ILS | 432.4% |
| 2022 Q1 | 499 Thousand ILS | 239.46% |
| 2021 Q2 | 176 Thousand ILS | -84.2% |
| 2021 Q1 | 1.11 Million ILS | 648.77% |
| 2021 FY | 2.95 Million ILS | 145.63% |
| 2021 Q3 | 1.52 Million ILS | 766.48% |
| 2021 Q4 | 147 Thousand ILS | -90.36% |
| 2020 FY | 1.2 Million ILS | -64.62% |
| 2020 Q4 | -203 Thousand ILS | -110.79% |
| 2020 Q2 | 127 Thousand ILS | 120.99% |
| 2020 Q3 | 1.88 Million ILS | 1381.89% |
| 2020 Q1 | -605 Thousand ILS | -135.07% |
| 2019 Q4 | 1.72 Million ILS | 7.81% |
| 2019 FY | 3.39 Million ILS | 292.35% |
| 2019 Q3 | 1.6 Million ILS | 57.33% |
| 2019 Q1 | -947 Thousand ILS | -262.71% |
| 2019 Q2 | 1.01 Million ILS | 207.39% |
| 2018 Q3 | -1.16 Million ILS | -532.84% |
| 2018 FY | -1.76 Million ILS | -24.91% |
| 2018 Q1 | -1.45 Million ILS | -392.17% |
| 2018 Q2 | 268 Thousand ILS | 118.42% |
| 2018 Q4 | 582 Thousand ILS | 150.17% |
| 2017 Q2 | -604 Thousand ILS | 0.0% |
| 2017 FY | -1.41 Million ILS | -129.84% |
| 2017 Q4 | 498 Thousand ILS | 0.0% |
| 2017 Q3 | 498 Thousand ILS | 182.45% |
| 2017 Q1 | -604 Thousand ILS | -124.64% |
| 2016 Q1 | 224 Thousand ILS | -85.25% |
| 2016 FY | 4.73 Million ILS | 23.17% |
| 2016 Q4 | 2.45 Million ILS | 408.51% |
| 2016 Q3 | 482 Thousand ILS | -69.47% |
| 2016 Q2 | 1.57 Million ILS | 604.91% |
| 2015 Q2 | 1.28 Million ILS | -1.23% |
| 2015 Q1 | 1.29 Million ILS | 35.81% |
| 2015 Q3 | -252 Thousand ILS | -119.67% |
| 2015 FY | 3.84 Million ILS | 53.13% |
| 2015 Q4 | 1.51 Million ILS | 702.78% |
| 2014 Q2 | 1.22 Million ILS | 1678.26% |
| 2014 FY | 2.51 Million ILS | 329.73% |
| 2014 Q4 | 955 Thousand ILS | 140.55% |
| 2014 Q1 | 69 Thousand ILS | -85.65% |
| 2014 Q3 | 397 Thousand ILS | -67.64% |
| 2013 Q1 | -481 Thousand ILS | 0.0% |
| 2013 Q2 | -716 Thousand ILS | -48.86% |
| 2013 Q3 | 106 Thousand ILS | 114.8% |
| 2013 Q4 | 481 Thousand ILS | 353.77% |
| 2013 FY | -1.09 Million ILS | -163.62% |
| 2012 FY | 1.71 Million ILS | -56.25% |
| 2011 FY | 3.92 Million ILS | 2.05% |
| 2010 FY | 3.84 Million ILS | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|